About ACell
ACell is a company based in Lafayette (United States) founded in 1999 was acquired by Integra LifeSciences in December 2020.. ACell has raised $8.7 million across 1 funding round from investors including Integra LifeSciences. The company has 398 employees as of December 31, 2022. ACell operates in a competitive market with competitors including Kerecis, Humacyte, Kitotech Medical, microMend and CUTISS, among others.
- Headquarter Lafayette, United States
- Employees 398 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name A Cell Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.7 M (USD)
in 1 rounds
-
Latest Funding Round
$8.7 M (USD), Series A
Apr 22, 2011
- Investors
-
Employee Count
398
as on Dec 31, 2022
-
Acquired by
Integra LifeSciences
(Dec 16, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ACell
ACell has successfully raised a total of $8.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.7 million completed in April 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $8.7M
-
First Round
First Round
(22 Apr 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2011 | Amount | Series A - ACell | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ACell
ACell has secured backing from 1 investor. Prominent investors backing the company include Integra LifeSciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified medical devices are developed for healthcare applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ACell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ACell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Acell Comparisons
Competitors of ACell
ACell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Humacyte, Kitotech Medical, microMend and CUTISS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
Human tissue-based products are developed for vascular disease applications.
|
|
| domain | founded_year | HQ Location |
Developer of a device to close wounds, lacerations, and surgical incisions
|
|
| domain | founded_year | HQ Location |
Solutions for treating dermatological disorders are provided by microMend.
|
|
| domain | founded_year | HQ Location |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
|
| domain | founded_year | HQ Location |
Developer of biodegradable temporising matrix for treating traumatic wounds
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Acell
Frequently Asked Questions about ACell
When was ACell founded?
ACell was founded in 1999 and raised its 1st funding round 12 years after it was founded.
Where is ACell located?
ACell is headquartered in Lafayette, United States. It is registered at Lafayette, Louisiana, United States.
Is ACell a funded company?
ACell is a funded company, having raised a total of $8.7M across 1 funding round to date. The company's 1st funding round was a Series A of $8.7M, raised on Apr 22, 2011.
How many employees does ACell have?
As of Dec 31, 2022, the latest employee count at ACell is 398.
What does ACell do?
ACell was founded in 1999 as a regenerative medicine company focused on tissue repair and remodeling. Extracellular Matrix (ECM) technology, based on the Urinary Bladder Matrix (UBM) platform, is utilized to create products such as Wound Matrix, Burn Matrix, MicroMatrix, Pelvic Floor Matrix, and Surgical Matrix. Operations include development and manufacturing, with headquarters in Columbia and a facility in Lafayette, United States.
Who are ACell's investors?
ACell has 1 investor. Key investors include Integra LifeSciences.